The Marshfield Clinic Research Institute, a division of Marshfield Clinic, has joined TriNetX, a growing health research network, to bring the latest advancements in medical research to rural patients.
“Rural populations are greatly benefited by being given the opportunity to participate in clinical trials. This brings the latest advancements in medical research to the patients regardless of their location,” said Robert Haws, director of the Clinical Research Center at the Research Institute.
About the system
The Marshfield Clinic Health System is the largest private practice group in Wisconsin and one of the largest health systems providing care to a rural population in the US. It has more than 1,200 medical providers representing 90 specialties and subspecialties and has over 50 locations in 34 Wisconsin communities.
“TriNetX is the world’s largest and fastest-growing health research network made up of healthcare organizations and pharmaceutical companies who are collaborating and sharing real-world data to make clinical and observational research easier and more efficient,” said Bill Stetson, director of marketing for TriNetX.
Bringing physicians, sponsors, and patients closer
“One of the most important benefits for the Marshfield Clinic is to bring new therapies to their patients by attracting industry-sponsored clinical trials,” said Stetson. “The trial sponsors also benefit, by leveraging a larger real-world data set to design protocols, as well as gaining an additional study site with eligible patients that could participate in their future clinical trials.”
One of the greatest challenges for patient care is that clinical trials often are disconnected from physician care. Often operating as separate industries, doctors are unaware of the possible clinical trials available that can help treat their patients, especially in rural locations; this partnership allows Marshfield Clinic to bring new therapies to their patients regardless of location.
“The Marshfield Clinic Health System takes pride in providing personalized health care to our patients and our patients are interested in their doctors’ recommendations on clinical trials,” added Haws. “Teaming up with TriNetX permits physicians and patients to work together as a team to bring new opportunities for exploring cutting edge research.”
“TriNetX addresses the challenges of harmonizing disparate real-world data from all over the world, with security, governance, and privacy standards within which healthcare organizations are able to safely participate,” said Stetson.
TriNetX has an intuitive, browser-based software platform with advanced analytic and collaboration capabilities. This enables members of the network like Marshfield to leverage a larger data set and optimize clinical trials in aspects like design protocols, study site selection, and more; it also helps generate insight into evidence, conduct collaborative research, help publishing to peer-reviewed journals, and present at scientific conferences.
“Being a part of TriNetX, means access to real-world data, and access to relationships with peers at healthcare organizations all over the world, as well as with pharmaceutical leaders who are working together to leverage data to improve human health,” added Stetson.